Complement evasion strategies of pathogens-Acquisition of inhibitors and beyond

Molecular Immunology

Volumn 46, Issue 14, 2009, Pages 2808-2817

  Blom, Anna M ^a   Hallström, Teresia ^a   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Bacterial proteases; C3; C4b binding protein; Complement; Factor H; Serum resistance; Vitronectin

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR H; VITRONECTIN;

ASPERGILLUS FUMIGATUS; BACTERIAL IMMUNITY; BORRELIA; CANDIDA ALBICANS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; ESCHERICHIA COLI; FUNGUS IMMUNITY; HAEMOPHILUS INFLUENZAE; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; MICROBIAL IMMUNITY; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANIMALS; BACTERIA; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT FACTOR H; HISTOCOMPATIBILITY ANTIGENS; HUMANS; PEPTIDE HYDROLASES; PHAGOCYTOSIS; VITRONECTIN;

BACTERIA (MICROORGANISMS); MORAXELLA CATARRHALIS; STAPHYLOCOCCUS AUREUS;

EID: 68249086824     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.04.025     Document Type: Review

References (126)

1. Accardo P., Sanchez Corral P., Criado O., Garcia E., and Rodriguez de Cordoba S. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J. Immunol. 157 (1996) 4935-4939
2. Åkerström B., Lindqvist A., and Lindahl G. Binding properties of protein Arp, a bacterial IgA-receptor. Mol. Immunol. 28 (1991) 349-357
3. Alitalo A., Meri T., Chen T., Lankinen H., Cheng Z.Z., Jokiranta T.S., Seppala I.J., Lahdenne P., Hefty P.S., Akins D.R., and Meri S. Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J. Immunol. 172 (2004) 6195-6201
4. Andre I., Persson J., Blom A.M., Nilsson H., Drakenberg T., Lindahl G., and Linse S. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry 45 (2006) 4559-4568
5. Apicella M.A., Mandrell R.E., Shero M., Wilson M.E., Griffiss J.M., Brooks G.F., Lammel C., Breen J.F., and Rice P.A. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162 (1990) 506-512
6. Arko R.J. Animal models for pathogenic Neisseria species. Clin. Microbiol. Rev. 2 (Suppl.) (1989) S56-S59
7. Attia A.S., Ram S., Rice P.A., and Hansen E.J. Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect. Immun. 74 (2006) 1597-1611
8. Barnum S.R., and Dahlbäck B. C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus. Complement Inflamm. 7 (1990) 71-77
9. Beernink P.T., Welsch J.A., Bar-Lev M., Koeberling O., Comanducci M., and Granoff D.M. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein. Infect. Immun. 76 (2008) 4232-4240
10. Behnsen J., Hartmann A., Schmaler J., Gehrke A., Brakhage A.A., and Zipfel P.F. The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect. Immun. 76 (2008) 820-827
11. Bergmann S., Lang A., Rohde M., Agarwal V., Rennemeier C., Grashoff C., Preissner K.T., and Hammerschmidt S. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci. 122 (2009) 256-267
12. Blom A.M., Berggård K., Webb J.H., Lindahl G., Villoutreix B.O., and Dahlbäck B. Human C4b-binding protein has overlapping but not identical binding sites for C4b and streptococcal M proteins. J. Immunol. 164 (2000) 5328-5336
13. Blom A.M., Bergstrom F., Edey M., Diaz-Torres M., Kavanagh D., Lampe A., Goodship J.A., Strain L., Moghal N., McHugh M., Inward C., Tomson C., Fremeaux-Bacchi V., Villoutreix B.O., and Goodship T.H. A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity. J. Immunol. 180 (2008) 6385-6391
14. Blom A.M., Kask L., and Dahlbäck B. CCP1-4 of the C4b-binding protein α-chain are required for Factor I mediated cleavage of C3b. Mol. Immunol. 39 (2003) 547-556
15. Blom A.M., Rytkönen A., Vasquez P., Lindahl G., Dahlbäck B., and Jonsson A.-B. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4b-binding protein. J. Immunol. 166 (2001) 6764-6770
16. Blom A.M., Villoutreix B.O., and Dahlback B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch. Immunol. Ther. Exp. (Warsz) 52 (2004) 83-95
17. Brakhage A.A. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Curr. Drug Targets 6 (2005) 875-886
18. Brooks C.S., Vuppala S.R., Jett A.M., Alitalo A., Meri S., and Akins D.R. Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J. Immunol. 175 (2005) 3299-3308
19. Broome C.V. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr. Infect. Dis. J. 6 (1987) 779-782
20. Burman J.D., Leung E., Atkins K.L., O'Seaghdha M.N., Lango L., Bernado P., Bagby S., Svergun D.I., Foster T.J., Isenman D.E., and van den Elsen J.M. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J. Biol. Chem. 283 (2008) 17579-17593
21. Carlsson F., Berggård K., Stalhammar-Carlemalm M., and Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M Protein. J. Exp. Med. 198 (2003) 1057-1068
22. Carroll M.C. Complement and humoral immunity. Vaccine 26S (2008) 128-133
23. Dahlbäck B., Smith C.A., and Müller Eberhard H.J. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc. Natl. Acad. Sci. USA 80 (1983) 3461-3465
24. Duensing T.D., and Putten J.P. Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge. Biochem. J. 334 Pt 1 (1998) 133-139
25. Estaller C., Schwaeble W., Dierich M., and Weiss E.H. Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts. Eur. J. Immunol. 21 (1991) 799-802
26. Fischetti V.A. Streptococcal M protein: moelcular design and biological behavior. Clin. Microbiol. Rev. 2 (1989) 285-314
27. Fisher-Hoch S.P., and Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin. Infect. Dis. 21 (1995) 897-904
28. Gerold G., Ajaj K.A., Bienert M., Laws H.J., Zychlinsky A., and de Diego J.L. A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin. Nat. Immunol. 9 (2008) 761-768
29. Granoff D.M., Welsch J.A., and Ram S. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect. Immun. 77 (2009) 764-769
30. Hallstrom T., Jarva H., Riesbeck K., and Blom A.M. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178 (2007) 6359-6366
31. Hallstrom T., Trajkovska E., Forsgren A., and Riesbeck K. Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J. Immunol. 177 (2006) 430-436
32. Hallstrom T., Zipfel P.F., Blom A.M., Lauer N., Forsgren A., and Riesbeck K. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181 (2008) 537-545
33. Hammel M., Sfyroera G., Pyrpassopoulos S., Ricklin D., Ramyar K.X., Pop M., Jin Z., Lambris J.D., and Geisbrecht B.V. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 282 (2007) 30051-30061
34. Hammel M., Sfyroera G., Ricklin D., Magotti P., Lambris J.D., and Geisbrecht B.V. A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8 (2007) 430-437
35. Haupt K., Kraiczy P., Wallich R., Brade V., Skerka C., and Zipfel P.F. Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins. J. Infect. Dis. 196 (2007) 124-133
36. Haupt K., Reuter M., van den Elsen J., Burman J., Halbich S., Richter J., Skerka C., and Zipfel P.F. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog. 4 (2008) e1000250
37. Hellwage J., Meri T., Heikkila T., Alitalo A., Panelius J., Lahdenne P., Seppala I.J., and Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276 (2001) 8427-8435
38. Hillarp A., and Dahlbäck B. Novel subunit in C4b-binding protein required for protein S binding. J. Biol. Chem. 263 (1988) 12759-12764
39. Hillarp A., Hessing M., and Dahlbäck B. Protein S binding in relation to the subunit composition of human C4b-binding protein. FEBS Lett. 259 (1989) 53-56
40. Hol C., Verduin C.M., Van Dijke E.E., Verhoef J., Fleer A., and van Dijk H. Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. FEMS Immunol. Med. Microbiol. 11 (1995) 207-211
41. Horstmann R.D., Sievertsen H.J., Knobloch J., and Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85 (1988) 1657-1661
42. Jakab E., Paulsson M., Ascencio F., and Ljungh A. Expression of vitronectin and fibronectin binding by Candida albicans yeast cells. Apmis 101 (1993) 187-193
43. Janssen B.J., and Gros P. Structural insights into the central complement component C3. Mol. Immunol. 44 (2007) 3-10
44. Jarva H., Ngampasutadol J., Ram S., Rice P.A., Villoutreix B.O., and Blom A.M. Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein. J. Immunol. 179 (2007) 540-547
45. Jarva H., Ram S., Vogel U., Blom A.M., and Meri S. Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J. Immunol. 174 (2005) 6299-6307
46. Jenkins H.T., Mark L., Ball G., Persson J., Lindahl G., Uhrin D., Blom A.M., and Barlow P.N. Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor. J. Biol. Chem. 281 (2006) 3690-3697
47. Ji Y., McLandsborough L., Kondagunta A., and Cleary P.P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64 (1996) 503-510
48. Johnsson E., Thern A., Dahlbäck B., Heden L.O., Wikström M., and Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J. Immunol. 157 (1996) 3021-3029
49. Jongerius I., Kohl J., Pandey M.K., Ruyken M., van Kessel K.P., van Strijp J.A., and Rooijakkers S.H. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204 (2007) 2461-2471
50. Jozsi M., and Zipfel P.F. Factor H family proteins and human diseases. Trends Immunol. 29 (2008) 380-387
51. Kask L., Hillarp A., Ramesh B., Dahlbäck B., and Blom A.M. Structural requirements for the intra-cellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 41 (2002) 9349-9357
52. Kellogg D.S., Cohen I.R., Norins L.C., Schroeter A.L., and Reising G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J. Bacteriol. 96 (1968) 596-605
53. Kilian M. In: Murray P.R. (Ed). Haemophilus. Manual of Clinical Microbiology vol. 8 (2003), ASM Press, Washington, DC 623-635
54. Kim K.S., Itabashi H., Gemski P., Sadoff J., Warren R.L., and Cross A.S. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin. Invest. 90 (1992) 897-905
55. Kotarsky H., Gustafsson M., Svensson H.G., Zipfel P.F., Truedsson L., and Sjobring U. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding. Mol. Microbiol. 41 (2001) 817-826
56. Kotarsky H., Hellwage J., Johnsson E., Skerka C., Svensson H.G., Lindahl G., Sjobring U., and Zipfel P.F. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J. Immunol. 160 (1998) 3349-3354
57. Kraiczy P., Skerka C., Kirschfink M., Brade V., and Zipfel P.F. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur. J. Immunol. 31 (2001) 1674-1684
58. Lancefield R.C. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89 (1962) 307-313
59. Lee L.Y., Hook M., Haviland D., Wetsel R.A., Yonter E.O., Syribeys P., Vernachio J., and Brown E.L. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190 (2004) 571-579
60. Limper A.H., and Standing J.E. Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol. Lett. 42 (1994) 139-144
61. Loesche W.J., Syed S.A., Laughon B.E., and Stoll J. The bacteriology of acute necrotizing ulcerative gingivitis. J. Periodontol. 53 (1982) 223-230
62. Madico G., Welsch J.A., Lewis L.A., McNaughton A., Perlman D.H., Costello C.E., Ngampasutadol J., Vogel U., Granoff D.M., and Ram S. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 177 (2006) 501-510
63. Mallorqui-Fernandez N., Manandhar S.P., Mallorqui-Fernandez G., Uson I., Wawrzonek K., Kantyka T., Sola M., Thogersen I.B., Enghild J.J., Potempa J., and Gomis-Ruth F.X. A new autocatalytic activation mechanism for cysteine proteases revealed by Prevotella intermedia interpain A. J. Biol. Chem. 283 (2007) 2871-2882
64. Mark L., Spiller O.B., Villoutreix B.O., and Blom A.M. Kaposi's sarcoma-associated herpes virus complement control protein: KCP-complement inhibition and more. Mol. Immunol. 44 (2007) 11-22
65. Maruvada R., Blom A.M., and Prasadarao N.V. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology (2007)
66. Massari P., Ram S., Macleod H., and Wetzler L.M. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11 (2003) 87-93
67. McQuillen D.P., Gulati S., Ram S., Turner A.K., Jani D.B., Heeren T.C., and Rice P.A. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J. Infect. Dis. 179 (1999) 124-135
68. Meri S., and Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87 (1990) 3982-3986
69. Meri T., Blom A.M., Hartmann A., Lenk D., Meri S., and Zipfel P.F. The yeast and hyphal forms of Candida albicans bind complement regulator C4b-binding protein. Infect. Immun. 11 (2004) 6633-6641
70. Meri T., Cutler S.J., Blom A.M., Meri S., and Jokiranta T.S. Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect. Immun. 74 (2006) 4157-4163
71. Meri T., Hartmann A., Lenk D., Eck R., Wurzner R., Hellwage J., Meri S., and Zipfel P.F. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70 (2002) 5185-5192
72. Morfeldt E., Berggard K., Persson J., Drakenberg T., Johnsson E., Lindahl E., Linse S., and Lindahl G. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J. Immunol. 167 (2001) 3870-3877
73. Murphy T.F. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60 (1996) 267-279
74. Narkio-Makela M., Jero J., and Meri S. Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion. Clin. Exp. Immunol. 116 (1999) 401-409
75. Ngampasutadol J., Ram S., Blom A.M., Jarva H., Jerse A.E., Lien E., Goguen J., Gulati S., and Rice P.A. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc. Natl. Acad. Sci. USA 102 (2005) 17142-17147
76. Ngampasutadol J., Ram S., Gulati S., Agarwal S., Li C., Visintin A., Monks B., Madico G., and Rice P.A. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J. Immunol. 180 (2008) 3426-3435
77. Nordström T., Blom A.M., Forsgren A., and Riesbeck K. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b-binding protein through ubiquitous surface proteins A1 and A2. J. Immunol. 173 (2004) 4598-4606
78. Nordstrom T., Blom A.M., Tan T.T., Forsgren A., and Riesbeck K. Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J. Immunol. 175 (2005) 3628-3636
79. O'Brien J.P., Goldenberg D.L., and Rice P.A. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 62 (1983) 395-406
80. Okuda K., Kato T., Naito Y., Ono M., Kikuchi Y., and Takazoe I. Susceptibility of Bacteroides gingivalis to bactericidal activity of human serum. J. Dent. Res. 65 (1986) 1024-1027
81. Pandiripally V., Gregory E., and Cue D. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect. Immun. 70 (2002) 6206-6214
82. Pandiripally V., Wei L., Skerka C., Zipfel P.F., and Cue D. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect. Immun. 71 (2003) 7119-7128
83. Park S.Y., Kim K.M., Lee J.H., Seo S.J., and Lee I.H. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun. 75 (2007) 1861-1869
84. Persson J., Beall B., Linse S., and Lindahl G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog. 2 (2006) e47
85. Pfaller M., and Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 287-291
86. Poltermann S., Kunert A., von der Heide M., Eck R., Hartmann A., and Zipfel P.F. Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. J. Biol. Chem. 282 (2007) 37537-37544
87. Popadiak K., Potempa J., Riesbeck K., and Blom A.M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 178 (2007) 7242-7250
88. Potempa J., Golonka E., Filipek R., and Shaw L.N. Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteases. Mol Microbiol 57 (2005) 605-610
89. Potempa J., Pike R., and Travis J. Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol. Chem. 378 (1997) 223-230
90. Potempa J., Sroka A., Imamura T., and Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr. Protein Pept. Sci. 4 (2003) 397-407
91. Potempa, M., Potempa, J., Kantyka, T., Nguyen, K., Wawrzonek, K., Manandhar, S.P., Popadiak, K., Riesbeck, K., Eick, S., Blom, A.M., 2009. Interpain A, cysteine proteinase from prevotella intermedia inhibits complement by degrading complement factor C3. PLOS Pathogens 5, e1000316.
92. Prasadarao N.V., Blom A.M., Villoutreix B.O., and Linsangan L.C. A novel interaction of outer membrane protein A with C4b-binding protein mediates serum resistance of Escherichia coli K1. J. Immunol. 169 (2002) 6352-6360
93. Preissner K.T. Structure and biological role of vitronectin. Annu. Rev. Cell. Biol. 7 (1991) 275-310
94. Ram S., Cullinane M., Blom A.M., Gulati S., McQuillen D.P., Monks B.G., O' Connell C., Boden R., Elkins C., Pangburn M.K., Dahlbäck B., and Rice P.A. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 193 (2001) 281-296
95. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., and Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 4 (1998) 671-680
96. Ram S., Ngampasutadol J., Cox A.D., Blom A.M., Lewis L.A., St Michael F., Stupak J., Gulati S., and Rice P.A. Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance. Infect. Immun. 75 (2007) 4071-4081
97. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., and Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187 (1998) 743-752
98. Ramu P., Tanskanen R., Holmberg M., Lahteenmaki K., Korhonen T.K., and Meri S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett. 581 (2007) 1716-1720
99. Rice P.A., McCormack W.M., and Kasper D.L. Natural serum bactericidal activity against Neisseria gonorrhoeae from disseminated, localy invasive and uncomplicated disease. J. Immunol. 124 (1980) 2105-2109
100. Ripoche J., Day A.J., Harris T.J., and Sim R.B. The complete amino acid sequence of human complement factor H. Biochem. J. 249 (1988) 593-602
101. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41 (2004) 355-367
102. Sakiniene E., Bremell T., and Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin. Exp. Immunol. 115 (1999) 95-102
103. Schenkein H.A., and Berry C.R. Production of chemotactic factors for neutrophils following the interaction of Bacteroides gingivalis with purified C5. J. Periodontal Res. 23 (1988) 308-312
104. Schvartz I., Seger D., and Shaltiel S. Vitronectin. Int. J. Biochem. Cell Biol. 31 (1999) 539-544
105. Spreghini E., Gismondi A., Piccoli M., and Santoni G. Evidence for alphavbeta3 and alphavbeta5 integrin-like vitronectin (VN) receptors in Candida albicans and their involvement in yeast cell adhesion to VN. J. Infect Dis. 180 (1999) 156-166
106. St Geme III J.W. Nontypeable Haemophilus influenzae disease: epidemiology, pathogenesis, and prospects for prevention. Infect. Agents Dis. 2 (1993) 1-16
107. Stevenson B., El-Hage N., Hines M.A., Miller J.C., and Babb K. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect. Immun. 70 (2002) 491-497
108. Sundqvist G., and Johansson E. Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand. J. Dent. Res. 90 (1982) 29-36
109. Sundqvist G.K., Carlsson J., Herrmann B.F., Hofling J.F., and Vaatainen A. Degradation in vivo of the C3 protein of guinea-pig complement by a pathogenic strain of Bacteroides gingivalis. Scand. J. Dent. Res. 92 (1984) 14-24
110. Swanson J., Robbins K., Barrera O., Corwin D., Boslego J., Ciak J., Blake M., and Koomey J.M. Gonococcal pilin variants in experimental gonorrhea. J. Exp. Med. 165 (1987) 1344-1357
111. Tan T.T., Morgelin M., Forsgren A., and Riesbeck K. Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J. Infect. Dis. 195 (2007) 1661-1670
112. Terao Y., Kawabata S., Kunitomo E., Murakami J., Nakagawa I., and Hamada S. Fba, a novel fibronectin-binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol. Microbiol. 42 (2001) 75-86
113. Terao Y., Mori Y., Yamaguchi M., Shimizu Y., Ooe K., Hamada S., and Kawabata S. Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J. Biol. Chem. 283 (2008) 6253-6260
114. Thern A., Stenberg L., Dahlbäck B., and Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 154 (1995) 375-386
115. Toapanta F.R., and Ross T.M. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol. Res. 36 (2006) 197-210
116. Tsao N., Tsai W.H., Lin Y.S., Chuang W.J., Wang C.H., and Kuo C.F. Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem. Biophys. Res. Commun. 339 (2006) 779-784
117. Upadhyay A., Burman J.D., Clark E.A., Leung E., Isenman D.E., van den Elsen J.M., and Bagby S. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J. Biol. Chem. 283 (2008) 22113-22120
118. Vogl G., Lesiak I., Jensen D.B., Perkhofer S., Eck R., Speth C., Lass-Florl C., Zipfel P.F., Blom A.M., Dierich M.P., and Wurzner R. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol. Immunol. 45 (2008) 1485-1493
119. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 10 (1996) 79-88
120. Ward M.E., Watt P.J., and Glynn A.A. Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature 227 (1970) 382-384
121. Weiser J.N., and Gotschlich E.C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 59 (1991) 2252-2258
122. Wingrove J.A., DiScipio R.G., Chen Z., Potempa J., Travis J., and Hugli T.E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267 (1992) 18902-18907
123. Wolff K., and Stern A. The class 3 outer membrane protein (PorB) of Neisseria meningitidis: gene sequence and homology to the gonococcal porin PIA. FEMS Microbiol. Lett. 67 (1991) 179-185
124. Woodman M.E., Cooley A.E., Miller J.C., Lazarus J.J., Tucker K., Bykowski T., Botto M., Hellwage J., Wooten R.M., and Stevenson B. Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection. Infect. Immun. 75 (2007) 3131-3139
125. Wooster D.G., Maruvada R., Blom A.M., and Prasadarao N.V. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 117 (2006) 482-493
126. Zipfel P.F., Skerka C., Hellwage J., Jokiranta S.T., Meri S., Brade V., Kraiczy P., Noris M., and Remuzzi G. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30 (2002) 971-978